Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: Correlation with hormonal and visual responses to octreotide

Clinical Endocrinology

Volumn 47, Issue 5, 1997, Pages 589-598

  Borson Chazot, Françoise ^a   Houzard, Claire ^a   Ajzenberg, Christiane ^b   Nocaudie, Marie ^c   Duet, Michèle ^b   Mundler, Olivier ^b   Marchandise, Xavier ^c   Epelbaum, Jacques ^b   De Alzaga, Maria Gomez ^d   Schäfer, Judith ^d   Meyerhof, Wolfgang ^d   Sassolas, Geneviève ^a,e   Warnet, André ^b  

^a Service de Medecine Nucleaire   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c INSERM   (France)

^d UNIVERSITY OF POTSDAM   (Germany)

^e HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR;

ACROMEGALY; ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HORMONE BINDING; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; SCINTIGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 9844226192     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.3361119.x     Document Type: Article

References (34)

1. Bertherat, J., Chanson, P., Dewailly, D., Dupuy, M., Jaquet, P., Peillon, F. & Epelbaum, J. (1993) Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. Journal of Clinical Endocrinology and Metabolism, 77, 1577-1583.
2. Bruno J.F., Xu, Y., Song, J. & Berelowitz, M. (1993) Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology, 133, 2561-2567.
3. Colao, A., Ferone, D., Lastoria, S., Marzullo, P., Cerbone, G., Di Sarno, A., Longobardi, S., Merola, B., Salvatore, M. & Lombardi, G. (1996) Prediction of efficacy of octreotide therapy in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 81, 2356-2362.
4. Cozzi, I., Oppizzi, G., Orlandi, P., Dallabonzana, D., Strada, S., Benini, Z., Chiodini, I., Possa, M. & Spinelli, F. (1995) Pentetreotide scintigraphy in pituitary adenomas. Abstr. 778, 76th Annual Meeting of the Endocrine Society. Washington, DC, USA.
5. De Bruin, T.W.A., Kwekkeboom, D.J., Vant Verlaat, J.W., Reubi, J.C., Krenning, E.P., Lamberts, S.W.J. & Croughs, R.J.M. (1992) Clinically non-functioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. Journal of Clinical Endocrinology and Metabolism, 75, 1310-1317.
6. Duet, M., Mundler, O., Ajzenberg, C., Berolati, B., Chodin, P., Duranteau, L. & Warnet, A. (1994) Somatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index. European Journal of Nuclear Medicine, 21, 647-650.
7. Epelbaum, J., Enjalbert, A., Krantic, S., Musset, F., Bertrand, P., Rasolonjanahary, R., Shu, C. & Kordon, C. (1987) Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase. Endocrinology, 121, 2177-2185.
8. Epelbaum, J., Bertherat, J., Prevost, G., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D. & Plouin, P.F. (1995) Molecular and pharmacological characterization of somatostatin receptor in adrenal, extra adrenal and malignant pheochromocytomas. Journal of Clinical Endocrinology and Metabolism, 80, 1837-1844.
9. I23I-SDZ-204-090). Journal of Clinical Endocrinology and Metabolism, 73, 850-856.
10. Greenman, Y. & Melmed, S. (1994) Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 78, 398-403.
11. Greenman, V. & Melmed, S. (1994) Expression of three somatostatin receptors subtypes in pituitary tumors: evidence of preferential sst5 expression in the mammosomatotroph lineage. Journal of Clinical Endocrinology and Metabolism, 79, 724-729.
12. Hukovic, N., Panetta, R., Kumar, U. & Patel, Y. (1996) Agonist-dependent regulation of cloned human somatostatin receptor types 1-5: subtype selective internalization or up-regulation. Endocrinology, 137, 4046-4049.
13. Ikuyama, S., Nawata, H., Kato, K., Karashima, T., Ibayashi, H. & Nakagaki, H. (1985) Specific Somatostatin receptors on human pituitary adenoma cell membranes. Journal of Clinical Endocrinology and Metabolism, 61, 666-671.
14. Ikuyama, S., Nawata, H., Kato, K., Karashima, T., Ibayashi, H. & Nakagaki, H. (1986) Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients. Journal of Clinical Endocrinology and Metabolism, 62, 729-733.
15. John, M., Meyerhof, M.J., Richter, D., Waser, B., Shaer, J.C., Scherübl, H., Boese-Langraf, J., Neuhaus, P., Ziske, C., Mölling, K., Riecken, E.O., Reubi, J.C. & Wiedenmann, B. (1996) Positive somatostatin receptor scinitgraphy correlates with the presence of somatostatin receptor subtype 2. Gut, 38, 33-39.
16. Katznelson, L., Oppenheim, D.S., Coughlin, J.F., Kliman, B., Schoenfeld, D.A. & Klibanski, A. (1992) Chronic somatostatin analog administration in patients with α-subunit-secreting pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 75, 1318-1325.
17. 3] octreotide: the Rotterdam experience with more than 1000 patients. European Journal of Nuclear Medicine, 20, 716-731.
18. Kwekkeboom, D.-J., Krenning, E.-P. & Lamberts, S.W.J. (1991) Clinically non-functioning pituitary adenomas: in vivo receptor imaging and in vitro hormone responses In Pituitary Adenomas: New Trends in Basic and Clinical Research (eds G. Faglia, P. Beck-Peccoz, B. Ambrosi, P. Travaglini & A. Spada), pp. 359-365. Elsevier Science, Amsterdam.
19. Lahlou, N., Le Nestour, F. & Chanson, P. (1993) Inhibin and folliculin-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumor volume in men. Clinical Endocrinology, 38, 301-309.
20. Lamberts, S.W.J., Krenning, E.P. & Reubi, J.C. (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Reviews, 12, 450-482.
21. Miller, G.M., Alexander, J.M., Bikkal, H.A., Katznelson, L., Zervas, H.T. & Klibanski, A. (1995) Somatostatin receptor subtype gene expression in pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 80, 1386-1392.
22. Moyer, D., Bell, G.L., Berelowitz, M., Epelbaum, J. & Feniuk, W. (1995) Classification and nomenclature of ssr. Trends in Pharmalogical Sciences, 16, 86-88.
23. Moyse, E., Le Dafniet, M., Epelbaum, J., Pagesy, P., Peillon, F., Kordon, C. & Enjalbert, A. (1985) Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 61, 98-103.
24. Patel, Y.C. & Srikant, C.B. (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (h sst rl-5). Endocrinology, 135(6), 2814-2817.
25. Pauwels, S., Delcourt, A., Leners, N., Maiter, D. & Jamar, F. (1995) Scintigraphic evaluation of somatostatin receptor density in pituitary macroadenomas. Abstr. 921, 42nd Meeting of Nuclear Medicine, Minneapolis, USA.
26. Plöckinger, U., Reichel, M., Fett, U., Saeger, W. & Quabbe, H.J. (1994) Preoperative octreotide treatment of growth hormone-secreting and clinically non-functioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. Journal of Clinical Endocrinology and Metabolism, 79, 1416-1423.
27. Reubi, J.C. & Landolt, A.M. (1984) High density of somatostatin receptors in pituitary tumors from acromegalic patients. Journal of Clinical Endocrinology and Metabolism, 59, 1148-1151.
28. Reubi, J.C. & Landolt, A.M. (1989) The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. Journal of Clinical Endocrinology and Metabolism, 68, 844-850.
29. Sassolas, G., Garry, J., Cohen, R., Bastuji, H., Vermeulen, E., Cabrera, P., Roussel, B. & Jouvet, M. (1986) Nocturnal continuous infusion of growth hormone-releasing hormone results in a dose dependant accentuation of episodic growth hormone secretion in normal men. Journal of Clinical Endocrinology and Metabolism, 63, 1016-1022.
30. Sassolas, G., Serusclat, P., Claustrat, B., Trouillas, J., Merabet, S., Cohen, R. & Souquet, J.-C. (1988) Plasma Alpha sub-unit levels during the treatment of pituitary adenomas with the somatostatin analogue SMS 201-995. Hormone Research, 29, 124-128.
31. Sassolas, G., Harris, A.G. & James-Deidier, A. (1990) Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. Journal of Clinical Endocrinology and Metabolism, 71, 391-398.
32. Sassolas, G., Trouillas, J., Treluyer, C., Perrin, G. (1993) Management of nonfunctioning pituitary adenomas. Acta Endocrinologica, 129 (suppl. 1), 21-26.
33. Ur, E., Mather, S.J., Bomanji, J., Ellison, D., Britton, K.E., Grossman, A.B., Wass, J.A.H. & Besser, G.M. (1992) Pituitary imaging using a labelled somatostatin analogue in acromegaly. Clinical Endocrinology, 36, 147-150.
34. Warnet, A., Timsit, J., Chanson, P., Guillausseau, P.J., Zamfirescu, F., Harris, A.G., Derome, P., Cophignon, J. & Lubetzki, J. (1989) The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas. Journal of Neurosurgery, 71, 687-691.